Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:e9050-e9051
doi: 10.1161/01.CIR.0000136295.14896.E0
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SoRelle, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SoRelle, R.

(Circulation. 2004;109:e9050-e9051.)
© 2004 American Heart Association, Inc.

Cardiovascular News

Ruth SoRelle, MPH

Circulation Newswriter


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Renal Transplant Patient Survival Similar After CABG, PCI

A retrospective study in this week’s issue of the journal Circulation (Circulation. 2004;109:2866–2871) found comparable survival rates after coronary artery bypass graft surgery and percutaneous intervention in patients who have had a kidney transplantation.

In this study, led by Charles A. Herzog, MD, of the Cardiovascular Special Studies Center, United States Renal Data System in Minnesota and the University of Minneapolis in Minnesota, researchers analyzed data from the records of renal transplant recipients who underwent a coronary revascularization procedure for the first time between 1995 and 1999. They found that the mortality rate was 2.3% among the 909 stent patients, 4.3% among the 652 percutaneous transluminal angioplasty patients, 9.4% among the 288 coronary artery bypass patients who did not receive the internal mammary graft, and 5% among the 812 bypass patients who did receive the internal mammary artery graft. At 2 years, the survival rate was 82.5% for stent patients, 81.6% for percutaneous transluminal angioplasty patients, 74.4% for coronary artery bypass patients who did not receive the internal mammary artery graft, and 82.7% for those bypass patients who did receive the internal mammary artery graft. There was no significant difference in the relative risks of all-cause and cardiac death among the different groups, the researchers concluded.

"We conclude that renal transplant recipients have comparable long-term survival after surgical and percutaneous coronary revascularization procedures. Our data suggest that the most favorable long-term outcome (after adjustment for comorbid conditions) is associated with CAB [coronary artery bypass] surgery. Any definitive conclusion . . . [Full Text of this Article]